• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰腺导管腺癌发生过程中的微生物群和真菌群失调

Micro- and Mycobiota Dysbiosis in Pancreatic Ductal Adenocarcinoma Development.

作者信息

Bellotti Ruben, Speth Cornelia, Adolph Timon E, Lass-Flörl Cornelia, Effenberger Maria, Öfner Dietmar, Maglione Manuel

机构信息

Department of Visceral, Transplant and Thoracic Surgery, Center of Operative Medicine, Medical University of Innsbruck, 6020 Innsbruck, Austria.

Institute of Hygiene and Medical Microbiology, Medical University of Innsbruck, 6020 Innsbruck, Austria.

出版信息

Cancers (Basel). 2021 Jul 8;13(14):3431. doi: 10.3390/cancers13143431.

DOI:10.3390/cancers13143431
PMID:34298645
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8303110/
Abstract

BACKGROUND

Dysbiosis of the intestinal flora has emerged as an oncogenic contributor in different malignancies. Recent findings suggest a crucial tumor-promoting role of micro- and mycobiome alterations also in the development of pancreatic ductal adenocarcinoma (PDAC).

METHODS

To summarize the current knowledge about this topic, a systematic literature search of articles published until October 2020 was performed in MEDLINE (PubMed).

RESULTS

An increasing number of publications describe associations between bacterial and fungal species and PDAC development. Despite the high inter-individual variability of the commensal flora, some studies identify specific microbial signatures in PDAC patients, including oral commensals like and or Gram-negative bacteria like . The role of spp. remains unclear. Recent isolation of from PDAC tissue suggest also the mycobiota as a crucial player of tumorigenesis. Based on described molecular mechanisms and interactions between the pancreatic tissue and the immune system this review proposes a model of how the micro- and the mycobial dysbiosis could contribute to tumorigenesis in PDAC.

CONCLUSIONS

The presence of micro- and mycobial dysbiosis in pancreatic tumor tissue opens a fascinating perspective on PDAC oncogenesis. Further studies will pave the way for novel tumor markers and treatment strategies.

摘要

背景

肠道菌群失调已成为不同恶性肿瘤的致癌因素。最近的研究结果表明,微生物群和真菌群的改变在胰腺导管腺癌(PDAC)的发展中也起着关键的促肿瘤作用。

方法

为总结关于该主题的当前知识,于2020年10月在MEDLINE(PubMed)中对已发表的文章进行了系统的文献检索。

结果

越来越多的出版物描述了细菌和真菌物种与PDAC发展之间的关联。尽管共生菌群存在高度个体差异,但一些研究在PDAC患者中确定了特定的微生物特征,包括如[具体菌种1]和[具体菌种2]等口腔共生菌或如[具体菌种3]等革兰氏阴性菌。[具体菌种4]的作用仍不清楚。最近从PDAC组织中分离出[具体菌种5]也表明真菌群是肿瘤发生的关键因素。基于所描述的胰腺组织与免疫系统之间的分子机制和相互作用,本综述提出了一个关于微生物群和真菌群失调如何促进PDAC肿瘤发生的模型。

结论

胰腺肿瘤组织中微生物群和真菌群失调的存在为PDAC的肿瘤发生开辟了一个引人入胜的视角。进一步的研究将为新型肿瘤标志物和治疗策略铺平道路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d06/8303110/cc58222ee00e/cancers-13-03431-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d06/8303110/d1b570e0c761/cancers-13-03431-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d06/8303110/cc58222ee00e/cancers-13-03431-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d06/8303110/d1b570e0c761/cancers-13-03431-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d06/8303110/cc58222ee00e/cancers-13-03431-g002.jpg

相似文献

1
Micro- and Mycobiota Dysbiosis in Pancreatic Ductal Adenocarcinoma Development.胰腺导管腺癌发生过程中的微生物群和真菌群失调
Cancers (Basel). 2021 Jul 8;13(14):3431. doi: 10.3390/cancers13143431.
2
Fungi, host immune response, and tumorigenesis.真菌、宿主免疫反应与肿瘤发生。
Am J Physiol Gastrointest Liver Physiol. 2021 Aug 1;321(2):G213-G222. doi: 10.1152/ajpgi.00025.2021. Epub 2021 Jul 7.
3
Complement and Fungal Dysbiosis as Prognostic Markers and Potential Targets in PDAC Treatment.补体与真菌失调作为 PDAC 治疗的预后标志物和潜在靶点。
Curr Oncol. 2022 Dec 14;29(12):9833-9854. doi: 10.3390/curroncol29120773.
4
Integrated analysis of microbiome and metabolome reveals signatures in PDAC tumorigenesis and prognosis.微生物组和代谢组的综合分析揭示了 PDAC 肿瘤发生和预后的特征。
Microbiol Spectr. 2024 Nov 5;12(11):e0096224. doi: 10.1128/spectrum.00962-24. Epub 2024 Oct 10.
5
The Microbiome as a Potential Target for Therapeutic Manipulation in Pancreatic Cancer.微生物群作为胰腺癌治疗性干预的潜在靶点
Cancers (Basel). 2021 Jul 27;13(15):3779. doi: 10.3390/cancers13153779.
6
The Emerging Role of Microbiota and Microbiome in Pancreatic Ductal Adenocarcinoma.微生物群和微生物组在胰腺导管腺癌中的新作用
Biomedicines. 2020 Dec 3;8(12):565. doi: 10.3390/biomedicines8120565.
7
Microbial Associations with Pancreatic Cancer: A New Frontier in Biomarkers.胰腺癌的微生物关联:生物标志物的新前沿
Cancers (Basel). 2021 Jul 27;13(15):3784. doi: 10.3390/cancers13153784.
8
Pancreatic Ductal Adenocarcinoma and Nutrition: Exploring the Role of Diet and Gut Health.胰腺导管腺癌与营养:探究饮食和肠道健康的作用。
Nutrients. 2023 Oct 21;15(20):4465. doi: 10.3390/nu15204465.
9
Fungal ablation and transplantation of specific fungal species into PDAC tumor-bearing mice.将特定真菌物种进行真菌消融和移植到 PDAC 荷瘤小鼠中。
STAR Protoc. 2022 Aug 23;3(3):101644. doi: 10.1016/j.xpro.2022.101644. eCollection 2022 Sep 16.
10
The Landscape of Microbial Composition and Associated Factors in Pancreatic Ductal Adenocarcinoma Using RNA-Seq Data.利用RNA测序数据剖析胰腺导管腺癌中微生物组成及相关因素的格局
Front Oncol. 2021 May 31;11:651350. doi: 10.3389/fonc.2021.651350. eCollection 2021.

引用本文的文献

1
The human microbiota: a double-edged sword against the 'Sword of Damocles' in PDAC diagnosis and therapy.人类微生物群:在胰腺癌诊断和治疗中对抗“达摩克利斯之剑”的双刃剑。
Front Oncol. 2025 Jun 26;15:1519277. doi: 10.3389/fonc.2025.1519277. eCollection 2025.
2
The Oral Microbiome and Cancer.口腔微生物群与癌症
Adv Exp Med Biol. 2025;1472:151-170. doi: 10.1007/978-3-031-79146-8_10.
3
with Mycovirus as an Etiologic Factor for Acute Leukemias in Susceptible Individuals: Evidence and Discussion.以真菌病毒作为易感个体急性白血病的病因:证据与讨论

本文引用的文献

1
Metabolic Characterization of Plasma and Cyst Fluid from Cystic Precursors to Pancreatic Cancer Patients Reveal Metabolic Signatures of Bacterial Infection.代谢特征分析胰腺癌患者囊腔前体的血液和囊液,揭示了细菌感染的代谢特征。
J Proteome Res. 2021 May 7;20(5):2725-2738. doi: 10.1021/acs.jproteome.1c00018. Epub 2021 Mar 15.
2
Oral microbiome and pancreatic cancer.口腔微生物群与胰腺癌
World J Gastroenterol. 2020 Dec 28;26(48):7679-7692. doi: 10.3748/wjg.v26.i48.7679.
3
Circulating and Salivary Antibodies to Are Associated With Cystic Pancreatic Neoplasm Malignancy.
Biomedicines. 2025 Feb 17;13(2):488. doi: 10.3390/biomedicines13020488.
4
Exploring the microbiome: Uncovering the link with lung cancer and implications for diagnosis and treatment.探索微生物组:揭示与肺癌的联系及其对诊断和治疗的影响。
Chin Med J Pulm Crit Care Med. 2023 Sep 15;1(3):161-170. doi: 10.1016/j.pccm.2023.08.003. eCollection 2023 Sep.
5
IPIAD- an augmentation regimen added to standard treatment of pancreatic ductal adenocarcinoma using already-marketed repurposed drugs irbesartan, pyrimethamine, itraconazole, azithromycin, and dapsone.IPIAD——一种增效方案,添加到使用已上市的重新利用药物厄贝沙坦、乙胺嘧啶、伊曲康唑、阿奇霉素和氨苯砜对胰腺导管腺癌进行的标准治疗中。
Oncoscience. 2024 Feb 7;11:15-31. doi: 10.18632/oncoscience.594. eCollection 2024.
6
Intratumoral microbiota: implications for cancer onset, progression, and therapy.肿瘤内微生物群:对癌症发生、进展和治疗的影响。
Front Immunol. 2024 Jan 16;14:1301506. doi: 10.3389/fimmu.2023.1301506. eCollection 2023.
7
The Roles and Interactions of and in Oral and Gastrointestinal Carcinogenesis: A Narrative Review.和在口腔及胃肠道癌变中的作用与相互作用:一篇叙述性综述
Pathogens. 2024 Jan 20;13(1):93. doi: 10.3390/pathogens13010093.
8
The inflammatory response of human pancreatic cancer samples compared to normal controls.与人胰腺正常组织对照的胰腺癌样本的炎症反应。
PLoS One. 2023 Nov 1;18(11):e0284232. doi: 10.1371/journal.pone.0284232. eCollection 2023.
9
A pancreatic adenocarcinoma mimicking hepatoid carcinoma of uncertain histogenesis: A case report and literature review.一例组织发生不明的类似肝样癌的胰腺腺癌:病例报告及文献复习
Oncol Lett. 2023 Aug 28;26(4):442. doi: 10.3892/ol.2023.14029. eCollection 2023 Oct.
10
2bRAD-M reveals the difference in microbial distribution between cancerous and benign ovarian tissues.2bRAD-M揭示了癌性和良性卵巢组织之间微生物分布的差异。
Front Microbiol. 2023 Aug 24;14:1231354. doi: 10.3389/fmicb.2023.1231354. eCollection 2023.
循环抗体和唾液抗体与胰腺囊性肿瘤的恶性程度相关。
Front Immunol. 2020 Aug 28;11:2003. doi: 10.3389/fimmu.2020.02003. eCollection 2020.
4
The Pancreatic Microbiome is Associated with Carcinogenesis and Worse Prognosis in Males and Smokers.胰腺微生物群与男性和吸烟者的致癌作用及更差的预后相关。
Cancers (Basel). 2020 Sep 18;12(9):2672. doi: 10.3390/cancers12092672.
5
Intracellular Promotes the Tumorigenic Behavior of Pancreatic Carcinoma Cells.细胞内物质促进胰腺癌细胞的致瘤行为。
Cancers (Basel). 2020 Aug 18;12(8):2331. doi: 10.3390/cancers12082331.
6
Biliary Tract Carcinogenesis Model Based on Bile Metaproteomics.基于胆汁蛋白质组学的胆道癌发生模型
Front Oncol. 2020 Jul 24;10:1032. doi: 10.3389/fonc.2020.01032. eCollection 2020.
7
Detection of pancreatic ductal adenocarcinoma with galectin-9 serum levels.血清半乳糖凝集素-9水平检测用于胰腺导管腺癌。
Oncogene. 2020 Apr;39(15):3102-3113. doi: 10.1038/s41388-020-1186-7. Epub 2020 Feb 13.
8
Dectin-1 Binding to Annexins on Apoptotic Cells Induces Peripheral Immune Tolerance via NADPH Oxidase-2.Dectin-1 与凋亡细胞上的膜联蛋白结合通过 NADPH 氧化酶-2 诱导外周免疫耐受。
Cell Rep. 2019 Dec 24;29(13):4435-4446.e9. doi: 10.1016/j.celrep.2019.11.086.
9
Role of the complement system in the tumor microenvironment.补体系统在肿瘤微环境中的作用。
Cancer Cell Int. 2019 Nov 15;19:300. doi: 10.1186/s12935-019-1027-3. eCollection 2019.
10
Pancreatic cancer-educated macrophages protect cancer cells from complement-dependent cytotoxicity by up-regulation of CD59.胰腺癌相关巨噬细胞通过上调 CD59 保护癌细胞免受补体依赖性细胞毒性。
Cell Death Dis. 2019 Nov 4;10(11):836. doi: 10.1038/s41419-019-2065-4.